Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.25) by 88 percent. This is a 88.46 percent increase over losses of $(0.26) per share from the same period last year.
Why Applovin Stock Is Accelerating Higher Thursday
Applovin Corp (NASDAQ: APP) shares are ripping higher Thursday after the company reported better-than-expected financial results.
